Maximizing the benefits of antiretroviral therapy for key affected populations.
Grubb IR, Beckham SW, Kazatchkine M, Thomas RM, Albers ER, Cabral M, Lange J, Vella S, Kurian M, Beyrer C; IAS Treatment for Key Affected Populations Working Group.
Grubb IR, et al.
J Int AIDS Soc. 2014 Jul 18;17(1):19320. doi: 10.7448/IAS.17.1.19320. eCollection 2014.
J Int AIDS Soc. 2014.
PMID: 25043380
Free PMC article.